MPM BioVentures 2014 reports Entrada Therapeutics share disposal worth $1.89 million
Reuters2026/09/09 23:24- MPM BioVentures 2014 reported sales of 259,837 Entrada Therapeutics common shares from Sep. 4-9.
- Weighted-average sale prices were $7.11, $7.41, $7.13.
- Indirect beneficial ownership fell to 3,885,115 shares following the latest sale.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canada Says Oil Sands Have Policy Support Needed To Boost Output
European Central Bank Governing Council Member Nagel: AI Will Be a "Touchstone" for Europe’s Future
Nagel stated in Berlin that artificial intelligence (AI) will become a "touchstone" for testing whether Europe can unite and fully unleash its potential.
Cameo Resources appoints Duranya Sebabili director, Tanzania country manager
JPMorgan (JPM.US) approaches $1 trillion market capitalization, as competitor Bank of America declares: still very cheap!
According to Bank of America analysts, JPMorgan would still be considered cheap even if its market capitalization reached 1 trillion dollars.
Crypto prices
More
